158 related articles for article (PubMed ID: 17706830)
1. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet.
Chirico S; Dalmoro A; Lamberti G; Russo G; Titomanlio G
J Control Release; 2007 Sep; 122(2):181-8. PubMed ID: 17706830
[TBL] [Abstract][Full Text] [Related]
2. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
5. Controlled release from hydrogel-based solid matrices. A model accounting for water up-take, swelling and erosion.
Lamberti G; Galdi I; Barba AA
Int J Pharm; 2011 Apr; 407(1-2):78-86. PubMed ID: 21256940
[TBL] [Abstract][Full Text] [Related]
6. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
[TBL] [Abstract][Full Text] [Related]
7. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
Zeng A; Yuan B; Fu Q; Wang C; Zhao G
Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
[TBL] [Abstract][Full Text] [Related]
9. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
[TBL] [Abstract][Full Text] [Related]
11. A general code to predict the drug release kinetics from different shaped matrices.
Barba AA; d'Amore M; Chirico S; Lamberti G; Titomanlio G
Eur J Pharm Sci; 2009 Feb; 36(2-3):359-68. PubMed ID: 19022380
[TBL] [Abstract][Full Text] [Related]
12. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
Karavas E; Georgarakis E; Bikiaris D
Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
[TBL] [Abstract][Full Text] [Related]
13. Validation of macroscopic attenuated total reflection-Fourier transform infrared imaging to study dissolution of swelling pharmaceutical tablets.
van der Weerd J; Kazarian SG
Appl Spectrosc; 2004 Dec; 58(12):1413-9. PubMed ID: 15606953
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques.
Leskinen JT; Hakulinen MA; Kuosmanen M; Ketolainen J; Abrahmsén-Alami S; Lappalainen R
Int J Pharm; 2011 Feb; 404(1-2):142-7. PubMed ID: 21094229
[TBL] [Abstract][Full Text] [Related]
15. Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose.
Dorożyński P; Kulinowski P; Mendyk A; Jachowicz R
Int J Pharm; 2011 Feb; 404(1-2):169-75. PubMed ID: 21095225
[TBL] [Abstract][Full Text] [Related]
16. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
17. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
Viridén A; Wittgren B; Larsson A
Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
[TBL] [Abstract][Full Text] [Related]
18. Influence of ethanol on aspirin release from hypromellose matrices.
Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
[TBL] [Abstract][Full Text] [Related]
19. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
20. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
